Master in Vaccinology and Drug Development

24/12/2025

✨ Season’s Greetings from the Master in Vaccinology and Drug Development ✨

May this season bring peace, renewal, and inspiration for the year ahead.

Warm wishes!

22/12/2025

📘 New Release from Springer
Vaccines and Vaccinations for Adults: A European Textbook

A comprehensive and timely reference on adult vaccination, covering routine and emerging vaccines, immunization strategies, and policy perspectives across Europe.

🔍 From COVID-19, influenza, and RSV to vaccination recommendations for risk groups, this textbook offers evidence-based insights for healthcare professionals, researchers, and public health leaders.

👉 Explore the book:
https://link.springer.com/book/10.1007/978-3-032-04020-6

This textbook provides a comprehensive reference on adult vaccines and immunization practices tailored to the European context.

20/12/2025

🌍 Meet Our International Scientific Board 👩‍🔬👨‍🔬

At Master in Vaccinology and Drug Development we are proud to be guided by an exceptional International Scientific Board composed of globally recognized experts who bring deep expertise in vaccinology, pediatrics, clinical research, and public health. Their leadership ensures our program stays at the forefront of scientific excellence and real-world relevance.

🎓 Our Board Includes:
🔹 Emanuele Montomoli – Chairman and founder of Institute for Global Health

🔹 Sue Ann Costa Clemens – Founder and Head of Institute for Global Health

🔹 Fred Zepp – Chairman of the Pediatric department, University of Mainz
Member of the German Vaccine Policy Body – Stiko

🔹 Ananda Bandyopadhyay – Deputy Director, Polio Research, Gates Foundation, Seattle, USA

🔹 Steve Black – Professor of Pediatrics, Center for Global Health, University of Cincinnati Children’s Hospital, Cincinnati, USA

Follow us to learn more about the experts shaping tomorrow’s leaders in vaccinology and drug development! 🚀

ifgh.org

16/12/2025

💉🔬 Understanding the Science Behind Vaccine Development

For professionals in vaccinology, immunology, and pharmaceutical R&D, the World Health Organization provides a clear, evidence-based overview of the full vaccine development pathway — from early discovery to post-licensure monitoring.

According to , vaccine development involves:

• Preclinical research: in-depth laboratory and animal studies to characterize safety and immunogenicity.
• Phase 1 clinical trials: initial evaluation of safety and immune response in a small cohort.
• Phase 2 trials: optimization of dosing, schedule, and continued safety assessment in a larger population.
• Phase 3 trials: large-scale evaluation of efficacy and adverse event profiles across diverse groups.
• Post-authorization surveillance: continuous monitoring to ensure sustained safety and effectiveness in real-world use.

Reference (WHO):
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/how-are-vaccines-developed/?utm_source=chatgpt.com

At the Master in Vaccinology and Drug Development, we highlight resources that strengthen scientific literacy and support evidence-based decision-making in global public health. Advancing vaccine science requires continuous learning, transparency, and collaboration across disciplines. 🌍🔬

ifgh.org

12/12/2025

🌍 Universal Health Coverage Day

Today we join the global health community to reaffirm that health for all is a human right, not a privilege. Universal Health Coverage (UHC) means everyone, everywhere can access quality health services without financial hardship — from prevention and primary care to treatment and rehabilitation.

ifgh.org

11/12/2025

Proud to highlight the inspiring work of Dr. Sue Ann Costa Clemens, whose leadership in vaccinology and commitment to training the next generation continue to shape global health.

In the next episode of Getting to Zero, Dr. Clemens joins host Dr. Nginache Nampota-Nkomba, to talk about what next gen vaccinologists need to know and how graduates are changing vaccine practice internationally.

Thursday, December 11 at 12:00 p.m. ET.
➡️ https://youtu.be/Ng_StSnVwd8

Her early work as a pediatrician, particularly in low- and middle-income countries where limited access to care generates overwhelming demand, convinced Dr. ...

01/12/2025

🎥 Today we share this World Health Organization (WHO) video for World AIDS Day.

This reminder from highlights a powerful milestone in the HIV response: Lenacapavir, a twice-yearly long-acting drug that represents a major breakthrough in prevention and treatment.

Innovations like this can help close gaps in access, improve adherence, and bring life-changing options to communities most affected by HIV.

On December 1, we honor the progress made and acknowledge the work that remains.

Ending AIDS is possible—when science, equity, and human rights move forward together
Everyone deserves the chance to live healthy, supported, and stigma-free.

https://www.youtube.com/watch?v=rKX2JrqR_o0

Have you heard about Lenacapavir or LEN, a new drug WHO recommends to protect people at risk of HIV? For some people, taking daily pills is not easy. But Len...

01/12/2025

🌍 World AIDS Day

Today we honor the global fight against HIV/AIDS, remembering the millions of lives impacted and recognizing the ongoing work of scientists, healthcare professionals, and communities worldwide.

✨ Together, we move closer to a future without HIV/AIDS.

🔬 Education. Innovation. Impact.
ifgh.org

28/11/2025

🎓 Advancing Global Health Through Expertise.

The Master in Vaccinology and Drug Development prepares professionals to design, assess, and implement life-saving vaccines and therapeutics for populations worldwide.

👏With more than ten years of academic excellence, over 99% of graduates remain active in vaccinology or public health within five years — driving initiatives that reinforce global health systems and improve lives. 🌍💉

Learn more: ifgh.org

26/11/2025

🤝 Our Gratitude to the Sponsors

The Master in Vaccinology and Drug Development thrives thanks to the invaluable support of our sponsors. Your ongoing commitment helps us strengthen capabilities, train the next generation of vaccine experts, and advance global health—particularly in low- and middle-income countries.

Because of your support, our alumni are leading vaccine trials, reinforcing health systems, and creating meaningful impact in their communities across the globe.

🌍 Together, we’re building a healthier future.

▪️Gates Foundation
▪️Novartis
▪️Sanofi
▪️Takeda
▪️Valneva
▪️CureVac
▪️Grid Europe
▪️VisMederi Group
▪️CEPI
▪️VaxTrials
▪️Cevaxin
▪️Fundação Lemann
▪️Syneos Health
▪️International Vaccine Institute
▪️Clover Biopharmaceuticals
▪️University of Wisconsin-Madison Global Health Institute
▪️Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI)
▪️Arcturus Therapeutics

Co-managing entity: Fondazione Vismeredi

🌐 www.ifgh.org

25/11/2025

🌍 Building the future of global health, one expert at a time.

The Master in Vaccinology and Drug Development shapes professionals who drive progress in vaccine research, policy, and implementation across the world.

For more than a decade, our graduates have taken leadership roles in organizations that transform scientific discovery into life-saving solutions. 💉🎓

Join a community committed to advancing public health — where innovation meets impact.

Learn more: ifgh.org